pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Innovent Biologics Inc · news · pharmadog
← back to Innovent Biologics Inc
News mentioning Innovent Biologics Inc
12
stories
10d
RevMed, BeOne make clinical trial, Asia deal; MoonLake reports Phase 3 win
endpoints
25d
Summit, Merck must navigate new regulatory terrain in China-first cancer landscape
biospace
Jul 15, 26
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
biopharma dive
Jul 14, 26
In latest deal, Innovent seeds Spero's future beyond GSK-owned antibiotic
endpoints
Jun 30, 26
These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.
biopharma dive
Jun 26, 26
At BIO, tension over China biotech deal regulation looms
biopharma dive
Jun 5, 26
Innovent declares Phase 3 success for ADC that attracted huge Takeda deal
endpoints
Jun 4, 26
Otsuka showcases kidney drug data; Pfizer cuts an AI deal
biopharma dive
Jun 3, 26
House bill aims to crack down on China biotech deals
biopharma dive
May 29, 26
STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
stat
May 29, 26
Pfizer, Innovent strike $10B cancer drug deal
biopharma dive
May 29, 26
Pfizer strikes Innovent deal worth up to $10.5B for a dozen cancer programs
endpoints
